European 'Brain-Boosting' Drug Pushed as Supplement in U.S. — Study finds FDA-rejected supplement can deliver doses high above EU-approved range by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today November 25, 2019

https://www.medpagetoday.com/neurology/generalneurology/83558?xid=nl_medpageexclusive_2019-11-26&eun=g649657d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=MPTexclusives_112619&utm_term=NL_Gen_Int_Medpage_Exclusives_Active